Swiss Startup Tackles Tourette’s Syndrome Despite Recent Failures
In spite of recent failures of clinical trials from others in the field, Swiss company…
07/12/2020 - 3 minutes
Psychiatric disorders
Schizophrenia Treatments Could be Tested and Personalized Using Patients’ Blood
Scientists at the University of Cambridge have developed a way to screen treatments for schizophrenia…
08/05/2019 - 2 minutes
Slow-Release Drug Biotech IPO Raises €30M
The French biotech MedinCell, an injectable slow-release drug specialist, has received a shot of success…
09/10/2018 - 2 minutes
Schizophrenia and Drug Delivery Biotechs Sign a Major Pharma Partner
Santa Claus is not the only busy one in the weeks leading up to Christmas…
19/12/2017 - 2 minutes
British Researchers Find Thought Police to Treat Neurological Disorders
Cambridge University scientists have identified a chemical in the brain that blocks unwanted thoughts, offering a…
07/11/2017 - 3 minutes
Austrian Researchers build an improved Mini-Brain to support Psychiatry
Researchers from Austria and the UK have made new advances in engineering brain-like structures. These…
02/06/2017 - 2 minutes
“We want to be the Worldwide Leader in Microbiota”
Biotech entrepreneur Hervé Affagard, CEO of MaaT Pharma, tells the story behind the success of…
06/02/2017 - 5 minutes
Mind, Mood and Microbes: Harnessing the Power of Probiotics
The canals of Amsterdam have attracted us this week to the capital of the Netherlands,…
02/12/2016 - 1 minute
Drugging the Undruggable: New Acquisition to Boost GPCR Drugs
Heptares Therapeutics has acquired G7 Therapeutics to take control over its GPCR technology, boost its…
30/11/2016 - 2 minutes
World Mental Health Day: How is Biotech Helping the Cause?
Biotech is one of the main forces driving the development of effective therapies to treat neurological and…
11/10/2016 - 4 minutes
New Biomarkers could make Personalized Medicine for Depression
Researchers from King’s College London have succeeded in developing a blood test that can help choose…
14/06/2016 - 3 minutes
Sorry Scotland, Phase II Trial for Clinical Depression Fails against 55-Year Old Generic
I mean, Clinical depression is a tough indication for Biotech to tackle - particularly when facing…
16/02/2016 - 3 minutes
